ArticleGenes & development2016

UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia.

Aissa Benyoucef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.